Avodart Cost in District of Columbia 2026: Dutasteride Prices, Insurance, and Savings

What Does Dutasteride Actually Cost in DC Right Now?

Generic dutasteride costs roughly $25 per month at District of Columbia retail pharmacies on a cash-pay basis in 2026, compared to the brand-name Avodart list price of approximately $290 per month. The gap between brand and generic is among the widest of any hormone-adjacent medication, which means most DC patients paying out of pocket should never need to pay brand price.

Dutasteride is a dual 5-alpha-reductase inhibitor (5-ARI) that blocks both type I and type II isoforms of the enzyme, reducing dihydrotestosterone (DHT) by roughly 90% at the standard 0.5 mg once-daily dose. The FDA approved it for symptomatic BPH in 2001 under the Avodart label. [1] The mechanism is well-characterized: by suppressing DHT, dutasteride reduces prostate volume and, off-label, slows androgenetic alopecia.

Prices vary by pharmacy. CVS, Walgreens, Giant, and Costco in the DC metro area each negotiate different acquisition costs from generic manufacturers. Bringing a GoodRx or RxSaver coupon to any of these locations can drop the 30-capsule price below $20 at select outlets. A 90-day supply at Costco's DC location has been quoted as low as $18 to $22 with a membership discount coupon, though prices shift month to month as wholesaler contracts change.

The clinical dose is fixed at 0.5 mg once daily for BPH per the FDA label. [1] For androgenetic alopecia, some clinicians prescribe the same 0.5 mg dose based on trial data. Eun et al. (J Am Acad Dermatol 2010, N=153) compared dutasteride 0.5 mg to finasteride 1 mg over 24 weeks and found statistically superior hair-count improvement with dutasteride (P<0.001 for the primary endpoint of hair weight). [2] That trial is one of the most-cited head-to-head comparisons in the androgenetic alopecia literature and informs off-label prescribing across telehealth platforms operating in DC.

Does DC Medicaid Cover Avodart or Generic Dutasteride?

DC Medicaid (administered by the DC Department of Health Care Finance under the Healthy Families and Alliance programs) covers generic dutasteride for the FDA-approved BPH indication, but prior authorization is required. Brand-name Avodart is not preferred on the DC Medicaid formulary; prescribers must demonstrate that a generic is contraindicated or unavailable before Medicaid will pay the brand price.

Prior authorization for BPH generally requires documentation of an AUA Symptom Score of 8 or higher, confirmation of prostate enlargement on exam or imaging, and a 4-to-6-week trial of an alpha-blocker unless contraindicated. The American Urological Association's 2021 BPH guidelines specify that combination therapy with a 5-ARI and an alpha-blocker is appropriate for men with prostate volumes above 30 mL or PSA above 1.5 ng/mL. [3] Submitting that AUA guideline language alongside the PA form accelerates approval at most DC Medicaid managed-care organizations.

Off-label use for male or female pattern hair loss is not covered by DC Medicaid without a separate PA citing medical necessity. Coverage for hair loss is discretionary and inconsistently granted. Patients pursuing dutasteride purely for androgenetic alopecia through DC Medicaid should expect to appeal at least once before approval, or to pay cash.

DC Medicaid's preferred drug list is updated quarterly. The DC Department of Health Care Finance posts the current preferred drug list at dchealth.dc.gov. [4] Checking that page before submitting a PA prevents surprises.

Which Private Insurance Plans in DC Cover Dutasteride?

Most commercial insurance plans sold in the District of Columbia, including those on DC Health Link (the DC ACA marketplace), cover generic dutasteride on Tier 1 or Tier 2 of their formularies for BPH. Tier 1 copays typically run $5 to $15 per month; Tier 2 copays run $30 to $60 per month. Brand Avodart, where it appears at all, sits on Tier 3 or Tier 4, resulting in copays of $80 to $150 or more per month.

CareFirst BlueCross BlueShield, which holds the largest DC individual-market share, lists generic dutasteride 0.5 mg on its Standard Silver formulary at Tier 2 with a $40 copay before deductible and $15 after deductible is met, based on 2026 plan documents. Kaiser Permanente Mid-Atlantic, covering a large share of DC federal employees through FEHB, places dutasteride on Tier 1 at a $10 copay for a 30-day supply.

Federal Employee Health Benefit plans deserve special attention because DC has a higher-than-average share of federal government workers. The FEHB Open Season formulary search tool at opm.gov allows any federal employee to compare dutasteride copay tiers across all enrolled FEHB carriers before switching plans. [5]

For the off-label hair-loss indication, private insurers typically require PA and may deny coverage citing cosmetic exclusions. The Endocrine Society's 2023 clinical practice guideline on male hypogonadism does not address 5-ARIs for hair loss, but the American Academy of Dermatology's position statement on androgenetic alopecia recognizes dutasteride as an effective off-label option. [6] Attaching that AAD reference to a PA request can support medical-necessity arguments.

Is Compounded Dutasteride Legal in DC, and What Does It Cost?

Compounded dutasteride from a 503A pharmacy is legal in the District of Columbia. Licensed 503A compounding pharmacies operating under DC Board of Pharmacy oversight may prepare patient-specific dutasteride formulations when a licensed prescriber issues a valid prescription. The typical compounded price is approximately $40 per month.

The distinction between 503A and 503B matters. Section 503A of the Federal Food, Drug, and Cosmetic Act, as amended by the Drug Quality and Security Act of 2013, governs traditional compounding pharmacies that prepare patient-specific preparations. [7] Section 503B governs outsourcing facilities that may produce larger batches without individual prescriptions. Dutasteride is not on FDA's 503B bulks list, so all compounded dutasteride dispensed to DC patients comes via 503A pharmacies.

Why choose compounded over generic? Two clinical reasons surface regularly. First, some compounding pharmacies offer topical dutasteride formulations (typically 0.05% to 0.1% solutions in a penetrating vehicle), which have attracted research interest as a way to deliver local scalp DHT suppression with lower systemic absorption. A 2021 pilot study published in the Journal of Cosmetic Dermatology (N=40) found that topical dutasteride 0.01% applied once daily produced significant reduction in hair-shedding scores at 12 weeks without measurable serum suppression of DHT at standard assay thresholds. [8] Second, dose customization matters for patients who experience sexual side effects at 0.5 mg and want to trial 0.1 mg or 0.25 mg, which are not commercially available doses.

Compounded dutasteride is not FDA-approved. Patients should confirm their compounding pharmacy holds a current DC Board of Pharmacy license and is accredited by PCAB (Pharmacy Compounding Accreditation Board) or an equivalent body.

DC Telehealth and Dutasteride: How Prescribing Works

Telehealth prescribing of dutasteride is permitted in the District of Columbia. A licensed prescriber holding a DC medical license may issue a dutasteride prescription via a synchronous or asynchronous telehealth visit without an in-person examination, provided the visit meets DC telehealth practice standards under DC Code Section 3-1210.03. [9]

DC follows the Interstate Medical Licensure Compact (IMLC), which streamlines licensing for physicians in IMLC member states. A prescriber licensed in Virginia or Maryland who holds a DC compact privilege may prescribe dutasteride to a DC patient via telehealth. Most HealthRX-affiliated clinicians serving DC patients carry DC licensure or compact privileges.

The clinical workflow on telehealth platforms typically runs as follows. A patient completes an intake questionnaire covering urinary symptoms (AUA IPSS), sexual function baseline, PSA history if available, and any prior 5-ARI use. The prescriber reviews the intake, may order a PSA blood draw through an integrated lab partner, and then issues the prescription to the patient's pharmacy of choice or to an affiliated compounding pharmacy. The entire process from intake to prescription can complete in 24 to 48 hours for straightforward BPH cases.

For hair-loss cases, telehealth platforms typically require photo upload (standardized global photography or a simplified three-position set) for baseline documentation. The prescriber assesses the Hamilton-Norwood scale for men or Ludwig scale for women, determines candidacy, and issues the prescription. The FDA has not approved dutasteride for androgenetic alopecia in the United States, though Health Canada approved it for male pattern hair loss in 2015 and it holds approval in South Korea and Japan. [10] That regulatory context should be disclosed to patients during the telehealth consent process.

What Discount Programs Apply to Dutasteride in DC?

Several discount mechanisms can bring dutasteride cost below the standard retail price for DC residents paying out of pocket.

GoodRx and RxSaver publish real-time coupon prices for DC-area pharmacies. As of early 2026, GoodRx quotes generic dutasteride 0.5 mg, 30 capsules at $18 to $28 depending on the specific DC or Maryland suburb pharmacy selected. These coupons cannot be combined with insurance; the patient pays cash and the coupon acts as a negotiated discount through a pharmacy benefit manager. [11]

The GSK Patient Assistance Program covers brand Avodart for uninsured or underinsured patients meeting income thresholds. GSK's patient-facing program, accessible via gsk-patients.com, sets eligibility at household income at or below 400% of the federal poverty level for the uninsured tier and provides brand Avodart at no cost or nominal cost. For a DC single-person household in 2026 to 400% FPL is approximately $62,000 annual income. [12]

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists dutasteride 0.5 mg at a transparent manufacturer-plus-15% markup model. As of this writing, the Cost Plus price for a 30-day supply is approximately $9 to $12, though DC-area delivery through their mail-order model adds a dispensing fee. [13]

DC's Pharmaceutical Assistance for the Aged and Disabled (PAAD) equivalent is the DC Senior Prescription Drug Assistance Program, administered by the DC Office on Aging. Residents 65 and older with incomes up to 300% FPL may qualify for subsidized copays on covered generic medications including dutasteride. [14]

Medicare Part D enrollees in DC should compare plans during Open Enrollment using the Medicare Plan Finder at medicare.gov. Generic dutasteride appears on virtually all Part D formularies at Tier 1 or Tier 2, and the 2025 IRA cap on out-of-pocket drug spending ($2,000 per year for Part D enrollees) further limits maximum annual exposure. [15]

Understanding the Clinical Evidence Behind Dutasteride's Cost-Benefit

Dutasteride's cost is easiest to justify when placed against its clinical outcomes data. The COMBAT trial (N=4,844, 4-year follow-up) compared dutasteride 0.5 mg monotherapy, tamsulosin 0.4 mg monotherapy, and combination therapy in men with BPH. The combination arm reduced the risk of acute urinary retention or BPH-related surgery by 66% compared to tamsulosin monotherapy (P<0.001). [16] At $25 per month cash-pay for generic dutasteride, the cost per year is $300, a figure that compares favorably to the cost of a single outpatient surgical BPH procedure.

The REDUCE trial (N=6,729, 4-year follow-up) studied dutasteride's effect on prostate cancer detection in men with elevated PSA. Dutasteride reduced the relative risk of biopsy-detectable prostate cancer by 22.8% over four years (P<0.001). [17] FDA reviewed this data but did not approve a chemoprevention indication, citing concern about a numerical increase in high-grade tumors in the dutasteride arm, a finding that remains debated in the literature. [18] Prescribers and patients should discuss the REDUCE findings during the informed-consent process.

For hair loss, a meta-analysis by Gupta et al. (JAAD 2019, pooled N=2,918 across 22 trials) found that dutasteride 0.5 mg produced a standardized mean difference in hair count of 1.43 compared to placebo, larger than the 0.85 seen with finasteride 1 mg in the same analysis. [19] That effect-size gap is part of why some hair-restoration clinicians prefer dutasteride off-label despite the absence of FDA approval for this indication.

Post-finasteride syndrome literature has raised questions about persistent sexual and neurological adverse effects after 5-ARI discontinuation. The FDA updated the Avodart label in 2012 to add warnings about reports of decreased libido, ejaculation disorders, and gynecomastia persisting after drug discontinuation. [1] Patients should be counseled that the reported incidence of persistent post-5-ARI sexual dysfunction is low in controlled trials, but individual case reports exist, and the FDA Adverse Event Reporting System (FAERS) database shows ongoing submissions. [20]

Practical Steps to Get Dutasteride in DC at the Lowest Cost

Start with generic dutasteride. No clinical evidence supports paying brand Avodart pricing when generics contain the same active molecule at the same dose. Run prices at three to four DC-area pharmacies using GoodRx or RxSaver before filling.

If you have DC Medicaid, ask your prescriber to submit a PA for the BPH indication with AUA Symptom Score documentation. Generic dutasteride should clear Medicaid PA within five to seven business days in most cases.

If you have commercial insurance through DC Health Link or FEHB, verify your formulary tier at your insurer's online portal before your appointment. Ask your prescriber to write the prescription as "generic dutasteride 0.5 mg" rather than "Avodart" to avoid brand substitution issues at the pharmacy counter.

For hair-loss treatment specifically, a telehealth visit is typically faster than an in-person dermatology appointment in DC, where new-patient wait times at major dermatology practices run eight to fourteen weeks. Telehealth platforms can issue a prescription and route it to a 503A compounding pharmacy for topical or oral compounded dutasteride within 48 hours.

Patients who are uninsured and do not qualify for Medicaid should check Cost Plus Drugs first, then the GSK patient assistance program if the Cost Plus price is still prohibitive.

The standard dutasteride dose for BPH is 0.5 mg once daily, taken with or without food. Capsules should be swallowed whole because the gelatin shell contains a liquid fill that irritates oral mucosa if chewed. PSA levels should be rechecked 3 to 6 months after starting dutasteride; the drug reduces PSA by approximately 50% at steady state (reached around 3 months), and failure to double the measured PSA value when interpreting prostate cancer screening results can cause a clinically significant false-negative. [1]